Due to the fact that many studies have demonstrated that suppressing - CLU activity could enhance the efficacy of chemotherapeutic agents in eradicating cancerous cells, the downregulation or targeted silencing of the CLU gene may provide a promising future in terms of therapeutic interventions for oral cancer. This evidence concerns the gene CLU and lip and oral cavity carcinoma.